Synosis Raises $32.5 Million

Synosis Therapeutics Inc., a South San Francisco, Calif.-based CNS drug company spun out of EuroVentures early last year, has raised $32.5 million in VC funding from Versant Ventures, Abingworth Management, 5AM Ventures and < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />NovoAS. It also has signed a partnership with Roche, which includes Synosis acquiring five Roche drug candidates, including four Phase I molecules.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />